This ensures that researchers receive a reliable, high-integrity compound for their work, free from contaminants
It is not for human consumption or for use in any diagnostic, therapeutic, or clinical applications
This route loses 6075% of active peptide to hepatic first-pass metabolism and renal clearance before any meaningful dermal concentration is achieved
Supporting Microbial Balance: Helping to maintain a healthy microbiome
Pharmacies that invest in this testing can assign longer, more accurate BUDs
Gastrointestinal Cytoprotection Originally studied in gastric lesion models, BPC-157 showed protective effects on: Gastric mucosa Intestinal healing Ulcer repair Reference: Sikiric et al., 1993 Gastric mucosal protection PubMed: Experimentally Observed Benefits of BPC 157 Peptides Below are benefits observed in controlled experimental models